Verizon Secures $1 Billion Google Deal for AI Data Center Connectivity
Verizon has inked a major deal with Google, valued at more than $1 billion,…
Indian Pharma CEO Warns Tariffs Will Drive Up US Generic Drug Prices
The CEO of India's Dr. Reddy's Laboratories warns that U.S. President Trump's proposed tariffs…
APEC Nations Vow ‘Strong Security’ for Open-Source AI Amid Global Control Push
In a significant move, 21 APEC economies, including the US and China, have released…
Asian Markets Tumble as AI Stocks Face Sell-Off Amid Soaring Brent Oil Prices
Asian stock markets saw a sharp decline today, driven by a significant sell-off in…
Kimberly-Clark: A Smart Buy with Favorable Risk/Reward, According to Jay Woods
Jay Woods suggests Kimberly-Clark (KMB) offers a favorable risk/reward opportunity for investors. The company,…
S&P 500 Futures Fluctuate as Oil Surge and Mixed Earnings Weigh on Markets
S&P 500 futures were flat in early trading Friday, failing to recover from a…
Trump’s New Global Tariffs: International Allies Reject Forced Labor Justification, Sparking Trade Tensions
President Donald Trump's administration has levied new global tariffs ranging from 10% to 12.5%…
YouTube’s Ad Revenue Soars to $11.1 Billion, Closing Gap on Netflix: A Deep Dive into the Streaming Rivalry
Alphabet-owned YouTube recorded a record $11.1 billion in ad revenue in the second quarter,…
Wall Street Tumbles: Oil Soars, Consumer Stocks Sag, and Global Tariffs Loom for Next Session
As the Dow Industrials saw a significant dip, market attention pivoted to soaring oil…
Japan’s Inflation Rebounds: Core CPI Climbs to 1.6% in June as Soaring Oil Prices and Weak Yen Amplify Pressures
Japan's core inflation rate rose to 1.6% in June, its first increase since March,…
AI ETFs Surge in Popularity Despite Q2 Volatility, JPMorgan Report Reveals
A recent report by J.P. Morgan Asset Management reveals a significant surge in investor…
Eli Lilly Eyes 2027 Approval for Next-Gen Obesity Drug ‘Retatrutide’ After Landmark Trial Success
Eli Lilly announced it will seek approval for its next-generation obesity drug, retatrutide, in…
